Melanoma risk assessment based on relatives’ age at diagnosis

Yelena P. Wu, Wendy Kohlmann, Karen Curtin, Zhe Yu, Heidi A. Hanson, Mia Hashibe, Bridget G. Parsons, Jathine Wong, Joshua D. Schiffman, Douglas Grossman, Sancy Leachman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: The aim of this study was to determine risk for melanoma among individuals who have a first- or second-degree relative with a history of melanoma, based on the unaffected individual’s age and age at diagnosis of the relative. Methods: The study employed a case–control design using a statewide database linked with a Surveillance Epidemiology and End Results cancer registry. A population-based sample of individuals who received at least one diagnosis of first primary, malignant melanoma (n = 14,281), as well as their first- and second-degree relatives, was included. Control individuals with no history of melanoma (n = 70,889) were matched to cases on birth year, gender, race/ethnicity, and county at birth. Results: Risk for melanoma among relatives of melanoma patients declined with relative’s age and age at diagnosis. Individuals between ages 40 and 49 who are first-degree relatives of melanoma patients diagnosed between ages 40 and 49 had the greatest risk for melanoma compared with individuals without a first-degree relative with a melanoma history (HR 4.89; 95% CI 3.11–7.68). Increased melanoma risk among second-degree relatives of patients was typically lower than that for first-degree relatives. Conclusions: Risk for melanoma, at earlier ages than expected, is increased among relatives of individuals with a history of melanoma, particularly if the melanoma case was diagnosed at a young age. Further research on the relationship between age at diagnosis and relative’s melanoma risk could inform melanoma screening recommendations for individuals with a family history of the disease.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalCancer Causes and Control
DOIs
StateAccepted/In press - Dec 14 2017

Fingerprint

Melanoma
Parturition
Registries
Epidemiology
Databases

Keywords

  • Age at diagnosis
  • Early detection
  • Familial risk
  • Melanoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wu, Y. P., Kohlmann, W., Curtin, K., Yu, Z., Hanson, H. A., Hashibe, M., ... Leachman, S. (Accepted/In press). Melanoma risk assessment based on relatives’ age at diagnosis. Cancer Causes and Control, 1-7. https://doi.org/10.1007/s10552-017-0994-8

Melanoma risk assessment based on relatives’ age at diagnosis. / Wu, Yelena P.; Kohlmann, Wendy; Curtin, Karen; Yu, Zhe; Hanson, Heidi A.; Hashibe, Mia; Parsons, Bridget G.; Wong, Jathine; Schiffman, Joshua D.; Grossman, Douglas; Leachman, Sancy.

In: Cancer Causes and Control, 14.12.2017, p. 1-7.

Research output: Contribution to journalArticle

Wu, YP, Kohlmann, W, Curtin, K, Yu, Z, Hanson, HA, Hashibe, M, Parsons, BG, Wong, J, Schiffman, JD, Grossman, D & Leachman, S 2017, 'Melanoma risk assessment based on relatives’ age at diagnosis', Cancer Causes and Control, pp. 1-7. https://doi.org/10.1007/s10552-017-0994-8
Wu, Yelena P. ; Kohlmann, Wendy ; Curtin, Karen ; Yu, Zhe ; Hanson, Heidi A. ; Hashibe, Mia ; Parsons, Bridget G. ; Wong, Jathine ; Schiffman, Joshua D. ; Grossman, Douglas ; Leachman, Sancy. / Melanoma risk assessment based on relatives’ age at diagnosis. In: Cancer Causes and Control. 2017 ; pp. 1-7.
@article{9311a879f6d543618228676172efaa37,
title = "Melanoma risk assessment based on relatives’ age at diagnosis",
abstract = "Purpose: The aim of this study was to determine risk for melanoma among individuals who have a first- or second-degree relative with a history of melanoma, based on the unaffected individual’s age and age at diagnosis of the relative. Methods: The study employed a case–control design using a statewide database linked with a Surveillance Epidemiology and End Results cancer registry. A population-based sample of individuals who received at least one diagnosis of first primary, malignant melanoma (n = 14,281), as well as their first- and second-degree relatives, was included. Control individuals with no history of melanoma (n = 70,889) were matched to cases on birth year, gender, race/ethnicity, and county at birth. Results: Risk for melanoma among relatives of melanoma patients declined with relative’s age and age at diagnosis. Individuals between ages 40 and 49 who are first-degree relatives of melanoma patients diagnosed between ages 40 and 49 had the greatest risk for melanoma compared with individuals without a first-degree relative with a melanoma history (HR 4.89; 95{\%} CI 3.11–7.68). Increased melanoma risk among second-degree relatives of patients was typically lower than that for first-degree relatives. Conclusions: Risk for melanoma, at earlier ages than expected, is increased among relatives of individuals with a history of melanoma, particularly if the melanoma case was diagnosed at a young age. Further research on the relationship between age at diagnosis and relative’s melanoma risk could inform melanoma screening recommendations for individuals with a family history of the disease.",
keywords = "Age at diagnosis, Early detection, Familial risk, Melanoma",
author = "Wu, {Yelena P.} and Wendy Kohlmann and Karen Curtin and Zhe Yu and Hanson, {Heidi A.} and Mia Hashibe and Parsons, {Bridget G.} and Jathine Wong and Schiffman, {Joshua D.} and Douglas Grossman and Sancy Leachman",
year = "2017",
month = "12",
day = "14",
doi = "10.1007/s10552-017-0994-8",
language = "English (US)",
pages = "1--7",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Melanoma risk assessment based on relatives’ age at diagnosis

AU - Wu, Yelena P.

AU - Kohlmann, Wendy

AU - Curtin, Karen

AU - Yu, Zhe

AU - Hanson, Heidi A.

AU - Hashibe, Mia

AU - Parsons, Bridget G.

AU - Wong, Jathine

AU - Schiffman, Joshua D.

AU - Grossman, Douglas

AU - Leachman, Sancy

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Purpose: The aim of this study was to determine risk for melanoma among individuals who have a first- or second-degree relative with a history of melanoma, based on the unaffected individual’s age and age at diagnosis of the relative. Methods: The study employed a case–control design using a statewide database linked with a Surveillance Epidemiology and End Results cancer registry. A population-based sample of individuals who received at least one diagnosis of first primary, malignant melanoma (n = 14,281), as well as their first- and second-degree relatives, was included. Control individuals with no history of melanoma (n = 70,889) were matched to cases on birth year, gender, race/ethnicity, and county at birth. Results: Risk for melanoma among relatives of melanoma patients declined with relative’s age and age at diagnosis. Individuals between ages 40 and 49 who are first-degree relatives of melanoma patients diagnosed between ages 40 and 49 had the greatest risk for melanoma compared with individuals without a first-degree relative with a melanoma history (HR 4.89; 95% CI 3.11–7.68). Increased melanoma risk among second-degree relatives of patients was typically lower than that for first-degree relatives. Conclusions: Risk for melanoma, at earlier ages than expected, is increased among relatives of individuals with a history of melanoma, particularly if the melanoma case was diagnosed at a young age. Further research on the relationship between age at diagnosis and relative’s melanoma risk could inform melanoma screening recommendations for individuals with a family history of the disease.

AB - Purpose: The aim of this study was to determine risk for melanoma among individuals who have a first- or second-degree relative with a history of melanoma, based on the unaffected individual’s age and age at diagnosis of the relative. Methods: The study employed a case–control design using a statewide database linked with a Surveillance Epidemiology and End Results cancer registry. A population-based sample of individuals who received at least one diagnosis of first primary, malignant melanoma (n = 14,281), as well as their first- and second-degree relatives, was included. Control individuals with no history of melanoma (n = 70,889) were matched to cases on birth year, gender, race/ethnicity, and county at birth. Results: Risk for melanoma among relatives of melanoma patients declined with relative’s age and age at diagnosis. Individuals between ages 40 and 49 who are first-degree relatives of melanoma patients diagnosed between ages 40 and 49 had the greatest risk for melanoma compared with individuals without a first-degree relative with a melanoma history (HR 4.89; 95% CI 3.11–7.68). Increased melanoma risk among second-degree relatives of patients was typically lower than that for first-degree relatives. Conclusions: Risk for melanoma, at earlier ages than expected, is increased among relatives of individuals with a history of melanoma, particularly if the melanoma case was diagnosed at a young age. Further research on the relationship between age at diagnosis and relative’s melanoma risk could inform melanoma screening recommendations for individuals with a family history of the disease.

KW - Age at diagnosis

KW - Early detection

KW - Familial risk

KW - Melanoma

UR - http://www.scopus.com/inward/record.url?scp=85038117312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038117312&partnerID=8YFLogxK

U2 - 10.1007/s10552-017-0994-8

DO - 10.1007/s10552-017-0994-8

M3 - Article

C2 - 29243179

AN - SCOPUS:85038117312

SP - 1

EP - 7

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

ER -